Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Amgen 10.054, AstraZeneca 15.384.
Amgen vs AstraZeneca: Revenue Comparison
Amgen (AMGN) and AstraZeneca (AZN) are peers in GLP-1. Amgen reported revenue of $10.1B as of Q2 2026, compared with $15.4B for AstraZeneca. AstraZeneca leads on revenue.
Amgen's gross margin is 72.0% versus 83.6% for AstraZeneca. Amgen's net margin is 23.6% versus 16.3% for AstraZeneca.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Amgen, AstraZeneca.| Metric | Amgen | AstraZeneca |
|---|---|---|
| Market Cap | - | - |
| Revenue | $10.05B | $15.38B |
| Cost of Revenue | $2.81B | $2.52B |
| Gross Profit | $7.24B | $12.86B |
| Operating Income | $3.51B | $3.16B |
| Net Income | $2.38B | $2.51B |
| R&D Expense | $1.87B | $4.05B |
| Earnings Per Share | $4.37 | $1.59 |
| Gross Margin | 72.0% | 83.6% |
| Operating Margin | 35.0% | 20.6% |
| Net Profit Margin | 23.6% | 16.3% |
| Free Cash Flow | $3.49B | $2.13B |
| Cumulative Free Cash Flow | $169.18B | $121.22B |
| Operating Cash Flow | $4.00B | $2.89B |
| Cash & Equivalents | $13.99B | $4.89B |